- Home
- RVP vs VYNE Comparison
RVP vs VYNE Comparison
Compare RVP & VYNE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- RVP
- VYNE
- Stock Information
- Founded
- RVP 1994
- VYNE 2003
- Country
- RVP United States
- VYNE United States
- Employees
- RVP N/A
- VYNE N/A
- Industry
- RVP Medical/Dental Instruments
- VYNE Biotechnology: Pharmaceutical Preparations
- Sector
- RVP Health Care
- VYNE Health Care
- Exchange
- RVP Nasdaq
- VYNE Nasdaq
- Market Cap
- RVP 19.8M
- VYNE 16.0M
- IPO Year
- RVP 2001
- VYNE 2018
- Fundamental
- Price
- RVP $0.66
- VYNE $1.44
- Analyst Decision
- RVP
- VYNE Strong Buy
- Analyst Count
- RVP 0
- VYNE 2
- Target Price
- RVP N/A
- VYNE $6.25
- AVG Volume (30 Days)
- RVP 33.3K
- VYNE 1.3M
- Earning Date
- RVP 08-13-2025
- VYNE 08-13-2025
- Dividend Yield
- RVP N/A
- VYNE N/A
- EPS Growth
- RVP N/A
- VYNE N/A
- EPS
- RVP N/A
- VYNE N/A
- Revenue
- RVP $33,745,343.00
- VYNE $605,000.00
- Revenue This Year
- RVP N/A
- VYNE $42.51
- Revenue Next Year
- RVP N/A
- VYNE N/A
- P/E Ratio
- RVP N/A
- VYNE N/A
- Revenue Growth
- RVP N/A
- VYNE 43.03
- 52 Week Low
- RVP $0.56
- VYNE $0.85
- 52 Week High
- RVP $1.21
- VYNE $4.30
- Technical
- Relative Strength Index (RSI)
- RVP 49.53
- VYNE 56.49
- Support Level
- RVP $0.63
- VYNE $1.20
- Resistance Level
- RVP $0.67
- VYNE $1.49
- Average True Range (ATR)
- RVP 0.03
- VYNE 0.22
- MACD
- RVP 0.00
- VYNE 0.03
- Stochastic Oscillator
- RVP 49.25
- VYNE 53.15
About RVP Retractable Technologies Inc.
Retractable Technologies Inc designs, develops, manufactures, and markets safety syringes and other safety medical products for the healthcare profession. The company's products are the VanishPoint 0.5mL insulin syringe; 1mL tuberculin, insulin, and allergy antigen syringes; 0.5mL, 1mL, 2mL, 3mL, 5mL, and 10mL syringes; the small diameter tube adapter; the blood collection tube holder; the allergy tray; the IV safety catheter; the Patient Safe syringes; the Patient Safe Luer Cap; the VanishPoint Blood Collection Set; and the EasyPoint needle, as well as a standard 3mL syringe packaged with an EasyPoint needle. The company also sells VanishPoint autodisable syringes in the international market in addition to the Company's other products.
About VYNE VYNE Therapeutics Inc.
VYNE Therapeutics Inc is a biopharmaceutical company focused on developing proprietary, innovative and differentiated therapies for the treatment of immuno-inflammatory conditions. Its advanced product candidate is FMX114, which is being evaluated for the potential treatment of mild-to-moderate AD (atopic dermatitis). The company is also in the pre-clinical stages of developing products containing BET (Bromodomain and Extra-Terminal Domain) inhibitor compounds. Its products include AMZEEQ, ZILXI, and FCD105.